5AM Venture Management, LLC reported 16 holdings worth US$297M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
5AM Venture Management, LLC reported 16 holdings worth US$297M as of Sep 30, 2026. Largest: Latigo Biotherapeutics, Inc., Entrada Therapeutics, Inc. and Tyra Biosciences, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 16
- Value as reported
- US$297M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. | 7.33M | US$122M | 41.2% |
| Entrada Therapeutics, Inc. | 3.78M | US$24M | 8.1% |
| Tyra Biosciences, Inc. | 1.03M | US$22.5M | 7.6% |
| CAMP4 Therapeutics Corporation | 5.28M | US$21.3M | 7.2% |
| Artiva Biotherapeutics, Inc. | 2.35M | US$16.8M | 5.6% |
| Tectonic Therapeutic, Inc. | 607K | US$14.1M | 4.8% |
| Celldex Therapeutics, Inc. | 422K | US$13.7M | 4.6% |
| Zentalis Pharmaceuticals, Inc. | 3.95M | US$10.9M | 3.7% |
| Biohaven Ltd. | 739K | US$9.87M | 3.3% |
| MapLight Therapeutics, Inc. | 742K | US$7.56M | 2.5% |
| Silence Therapeutics PLC | 476K | US$5.2M | 1.8% |
| ALX Oncology Holdings Inc. | 3.06M | US$4.25M | 1.4% |
| Protara Therapeutics, Inc. | 1.37M | US$4.18M | 1.4% |
| EyePoint, Inc. | 1.05M | US$3.43M | 1.2% |
| Skye Bioscience, Inc. | 0 | US$0 | 0.00% |
| Surrozen, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC